Fig. 3

Univariate and multivariate analysis for risk factors associated with risk of myelofibrosis progression in the entire cohort. CVRF cardiovascular risk factors, ET essential thrombocythemia, HCT hematocrit, LDH lactate dehydrogenase, PLT platelet, PV polycythemia vera, TN triple-negative, WBC white blood count.